D.A. Davidson & Co’s Theravance Biopharma TBPH Stock Holding History

D.A. Davidson & Co’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4	Closed	–	–	2288
2015 Q2	$0	Buy	+4	New	+$62	﹤0.01%	2287

Other funds holding TBPH

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

FAM

Foundation Asset Management White Plains, New York $116M AUM 31.02% 1-Year Est. Return

D.A. Davidson & Co's TBPH Position: Q3 2015 in Review

D.A. Davidson & Co sold out of Theravance Biopharma (TBPH) in Q3 2015, closing a stake of 4 shares.

D.A. Davidson & Co first reported a position in TBPH in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 83 funds tracked by Wall St. Rank hold TBPH as of Q3 2015.

D.A. Davidson & Co reported no remaining Theravance Biopharma position as of Q3 2015 after selling out during the quarter.
D.A. Davidson & Co sold 4 Theravance Biopharma shares in Q3 2015.
D.A. Davidson & Co first reported a position in Theravance Biopharma in Q2 2015 and held it in 1 quarter.
D.A. Davidson & Co's Theravance Biopharma position peaked at $0 in Q2 2015.
83 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2015.

Based on D.A. Davidson & Co's 13F filing for Q3 2015, filed 13 Nov 2015.